These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2657348)

  • 1. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O; Pino ME; Valenzuela A
    Cardiology; 1987; 74(3):219-25. PubMed ID: 3594511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
    Neusy AJ; Valeri A
    J Hum Hypertens; 1990 Aug; 4(4):453-7. PubMed ID: 2258893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y; Gagné C
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension in the elderly with pindolol and clopamide.
    Persson I
    J Am Geriatr Soc; 1978 Aug; 26(8):337-40. PubMed ID: 670620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
    Nyberg G; Asplund J; Anagreus N; Aström B; Leppert J; Bergström R; Overmo J; Kullman S; Lessem J
    Lancet; 1982 Feb; 1(8268):355-8. PubMed ID: 6120347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
    Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
    Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
    Persson I
    Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW; Khokhar AM; Flax JS
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
    Faupel RP; Gotzen R
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.